Target

integrins αvβ5

4 products, 6 indications

Indications

advanced clear cell renal cell carcinoma (ccRCC) (1 products)

metastatic non-small cell lung cancer (1 products)

Stage III melanoma (1 products)

metastatic soft tissue sarcoma (1 products)

platinum-resistant/refractory epithelial ovarian cancer (1 products)

glioblastoma (1 products)

1 drug

Drug